Consistent with this speculation, clinical studies showed that levels of IL‐6 are dramatically upregulated in patients with sarcopenia after adjustment for potential confounders such as BMI and visceral fat tissue.471, 472, 473. The gene discussed is IL6; the disease is sarcopenia.